Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael James Hassett, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA172143 (HASSETT, MICHAEL JAMES) Mar 1, 2013 - Feb 28, 2019
    NIH
    Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Klein H, Mazor T, Siegel E, Trukhanov P, Ovalle A, Vecchio Fitz CD, Zwiesler Z, Kumari P, Van Der Veen B, Marriott E, Hansel J, Yu J, Albayrak A, Barry S, Keller RB, MacConaill LE, Lindeman N, Johnson BE, Rollins BJ, Do KT, Beardslee B, Shapiro G, Hector-Barry S, Methot J, Sholl L, Lindsay J, Hassett MJ, Cerami E. MatchMiner: an open-source platform for cancer precision medicine. NPJ Precis Oncol. 2022 Oct 06; 6(1):69. PMID: 36202909; PMCID: PMC9537311.
    Citations:    
  2. Leone JP, Hassett MJ, Leone J, Tolaney SM, Vallejo CT, Leone BA, Winer EP, Lin NU. Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer. Cancer. 2022 Nov 01; 128(21):3796-3803. PMID: 36069365.
    Citations:    Fields:    
  3. Trapani D, Tay-Teo K, Tesch ME, Roitberg F, Sengar M, Altuna SC, Hassett MJ, Genazzani AA, Kesselheim AS, Curigliano G. Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. Curr Oncol. 2022 08 16; 29(8):5774-5791. PMID: 36005193; PMCID: PMC9406873.
    Citations:    Fields:    
  4. Punglia RS, Hassett MJ. Variation in Cardiac Dose Explains a "Fraction" of the Disparities among Breast Cancer Patients. J Natl Cancer Inst. 2022 Aug 02. PMID: 35916721.
    Citations:    Fields:    
  5. McCleary NJ, Haakenstad EK, Cleveland JLF, Manni M, Hassett MJ, Schrag D. Framework for integrating electronic patient-reported data in routine cancer care: an Oncology Intake Questionnaire. JAMIA Open. 2022 Oct; 5(3):ooac064. PMID: 35898610; PMCID: PMC9315161.
    Citations:    
  6. Leone JP, Graham N, Tolaney SM, Leone BA, Freedman RA, Hassett MJ, Leone J, Vallejo CT, Winer EP, Lin NU, Tayob N. Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool. Eur J Cancer. 2022 09; 173:20-29. PMID: 35841843.
    Citations:    Fields:    
  7. Garcia Farina E, Rowell J, Revette A, Haakenstad EK, Cleveland JLF, Allende R, Hassett M, Schrag D, McCleary NJ. Barriers to Electronic Patient-Reported Outcome Measurement Among Patients with Cancer and Limited English Proficiency. JAMA Netw Open. 2022 07 01; 5(7):e2223898. PMID: 35867056; PMCID: PMC9308052.
    Citations:    Fields:    Translation:Humans
  8. Hassett MJ, Wong S, Osarogiagbon RU, Bian J, Dizon DS, Jenkins HH, Uno H, Cronin C, Schrag D. Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial. Trials. 2022 Jun 16; 23(1):506. PMID: 35710449; PMCID: PMC9202326.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  9. Tsangaris E, Edelen M, Means J, Gregorowitsch M, O'Gorman J, Pattanaik R, Dominici L, Hassett M, Witkowski ML, Schrieber K, Frank E, Carnie M, Pusic A. User-centered design and agile development of a novel mobile health application and clinician dashboard to support the collection and reporting of patient-reported outcomes for breast cancer care. BMJ Surg Interv Health Technol. 2022; 4(1):e000119. PMID: 35464815; PMCID: PMC8987795.
    Citations: 1     
  10. Hassett MJ, Tramontano AC, Uno H, Ritzwoller DP, Punglia RS. Geospatial Disparities in the Treatment of Curable Breast Cancer Across the US. JAMA Oncol. 2022 Mar 01; 8(3):445-449. PMID: 35084444; PMCID: PMC8796059.
    Citations: 1     Fields:    Translation:Humans
  11. Trapani D, Ginsburg O, Fadelu T, Lin NU, Hassett M, Ilbawi AM, Anderson BO, Curigliano G. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022 Mar; 104:102339. PMID: 35074727.
    Citations: 7     Fields:    Translation:Humans
  12. Upadhyay VA, Johnson BE, Landman AB, Hassett MJ. Real-World Analysis of Off-Label Use of Molecularly Targeted Therapy in a Large Academic Medical Center Cohort. JCO Precis Oncol. 2022 01; 6:e2100232. PMID: 35050710.
    Citations:    Fields:    Translation:Humans
  13. Hassett MJ, Cronin C, Tsou TC, Wedge J, Bian J, Dizon DS, Hazard-Jenkins H, Osarogiagbon RU, Wong S, Basch E, Austin T, McCleary N, Schrag D. eSyM: An Electronic Health Record-Integrated Patient-Reported Outcomes-Based Cancer Symptom Management Program Used by Six Diverse Health Systems. JCO Clin Cancer Inform. 2022 01; 6:e2100137. PMID: 34985914.
    Citations: 3     Fields:    Translation:Humans
  14. Nagra NS, Tsangaris E, Means J, Hassett MJ, Dominici LS, Bellon JR, Broyles J, Kaplan RS, Feeley TW, Pusic AL. Correction to: Time-Driven Activity-Based Costing in Breast Cancer Care Delivery. Ann Surg Oncol. 2021 Dec; 28(Suppl 3):899. PMID: 34546481.
    Citations:    Fields:    
  15. Nagra NS, Tsangaris E, Means J, Hassett MJ, Dominici LS, Bellon JR, Broyles J, Kaplan RS, Feeley TW, Pusic AL. ASO Visual Abstract: Time-Driven Activity-Based Costing (TDABC) in Breast Cancer Care Delivery. Ann Surg Oncol. 2021 Dec; 28(Suppl 3):599-600. PMID: 34378094.
    Citations:    Fields:    
  16. Barroso-Sousa R, Vaz-Luis I, Di Meglio A, Hu J, Li T, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, Partridge A, Burstein H, Waks AG, Tayob N, Trippa L, Tolaney SM, Hassett MJ, Winer EP, Lin NU. Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer. Oncologist. 2021 11; 26(11):927-933. PMID: 34472667.
    Citations:    Fields:    Translation:Humans
  17. Banegas MP, Hassett MJ, Keast EM, Carroll NM, O'Keeffe-Rosetti M, Fishman PA, Uno H, Hornbrook MC, Ritzwoller DP. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer. Value Health. 2022 01; 25(1):69-76. PMID: 35031101.
    Citations: 1     Fields:    Translation:Humans
  18. Ritzwoller DP, Hassett MJ, Uno H. Regarding the Utility of Unstructured Data and Natural Language Processing for Identification of Breast Cancer Recurrence. JCO Clin Cancer Inform. 2021 09; 5:1024-1025. PMID: 34637320.
    Citations:    Fields:    Translation:Humans
  19. Nagra NS, Tsangaris E, Means J, Hassett MJ, Dominici LS, Bellon JR, Broyles J, Kaplan RS, Feeley TW, Pusic AL. Time-Driven Activity-Based Costing in Breast Cancer Care Delivery. Ann Surg Oncol. 2022 Jan; 29(1):510-521. PMID: 34374913.
    Citations:    Fields:    Translation:Humans
  20. Leone JP, Vallejo CT, Hassett MJ, Leone J, Graham N, Tayob N, Freedman RA, Tolaney SM, Leone BA, Winer EP, Lin NU. Correction to: Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Res Treat. 2021 Aug; 189(1):305. PMID: 34231078.
    Citations: 2     Fields:    
  21. Kehl KL, Groha S, Lepisto EM, Elmarakeby H, Lindsay J, Gusev A, Van Allen EM, Hassett MJ, Schrag D. Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial-Ready Patients With Cancer. JCO Clin Cancer Inform. 2021 06; 5:622-630. PMID: 34097438; PMCID: PMC8240790.
    Citations:    Fields:    Translation:Humans
  22. Chua IS, Gaziel-Yablowitz M, Korach ZT, Kehl KL, Levitan NA, Arriaga YE, Jackson GP, Bates DW, Hassett M. Artificial intelligence in oncology: Path to implementation. Cancer Med. 2021 06; 10(12):4138-4149. PMID: 33960708.
    Citations: 10     Fields:    Translation:Humans
  23. Upadhyay VA, Landman AB, Hassett MJ. Landscape Analysis of Oncology Mobile Health Applications. JCO Clin Cancer Inform. 2021 05; 5:579-587. PMID: 34033510.
    Citations: 3     Fields:    Translation:Humans
  24. Leone JP, Vallejo CT, Hassett MJ, Leone J, Graham N, Tayob N, Freedman RA, Tolaney SM, Leone BA, Winer EP, Lin NU. Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Res Treat. 2021 Aug; 189(1):203-212. PMID: 33893907; PMCID: PMC8302525.
    Citations: 2     Fields:    Translation:Humans
  25. Lamba N, Kearney RB, Catalano PJ, Hassett MJ, Wen PY, Haas-Kogan DA, Aizer AA. Population-based estimates of survival among elderly patients with brain metastases. Neuro Oncol. 2021 04 12; 23(4):661-676. PMID: 33068418.
    Citations: 9     Fields:    Translation:Humans
  26. Azizoddin DR, Adam R, Kessler D, Wright AA, Kematick B, Sullivan C, Zhang H, Hassett MJ, Cooley ME, Ehrlich O, Enzinger AC. Leveraging mobile health technology and research methodology to optimize patient education and self-management support for advanced cancer pain. Support Care Cancer. 2021 Oct; 29(10):5741-5751. PMID: 33738594; PMCID: PMC8410657.
    Citations: 4     Fields:    Translation:Humans
  27. Asad S, Barcenas CH, Bleicher RJ, Cohen AL, Javid SH, Levine EG, Lin NU, Moy B, Niland J, Wolff AC, Hassett MJ, Stover DG. Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study. J Natl Compr Canc Netw. 2021 03 10; 19(7):797-804. PMID: 33691275; PMCID: PMC8564718.
    Citations: 5     Fields:    Translation:Humans
  28. Leone JP, Leone BA, Tayob N, Hassett MJ, Leone J, Freedman RA, Tolaney SM, Winer EP, Vallejo CT, Lin NU. Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry. Breast Cancer Res Treat. 2021 Jun; 187(3):843-852. PMID: 33590387.
    Citations: 3     Fields:    Translation:Humans
  29. Denduluri N, Somerfield MR, Chavez-MacGregor M, Comander AH, Dayao Z, Eisen A, Freedman RA, Gopalakrishnan R, Graff SL, Hassett MJ, King TA, Lyman GH, Maupin GR, Nunes R, Perkins CL, Telli ML, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2021 02 20; 39(6):685-693. PMID: 33079579.
    Citations: 21     Fields:    Translation:Humans
  30. Horiguchi M, Hassett MJ, Uno H. Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology. Clin Trials. 2020 12; 17(6):597-606. PMID: 32933339.
    Citations: 1     Fields:    Translation:Humans
  31. Yang DD, Buscariollo DL, Cronin AM, Weng S, Hughes ME, Bleicher RJ, Cohen AL, Javid SH, Edge SB, Moy B, Niland JC, Wolff AC, Hassett MJ, Punglia RS. Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer. Radiat Oncol. 2020 Aug 17; 15(1):198. PMID: 32799886.
    Citations: 2     Fields:    Translation:Humans
  32. Kehl KL, Xu W, Lepisto E, Elmarakeby H, Hassett MJ, Van Allen EM, Johnson BE, Schrag D. Natural Language Processing to Ascertain Cancer Outcomes From Medical Oncologist Notes. JCO Clin Cancer Inform. 2020 08; 4:680-690. PMID: 32755459.
    Citations: 8     Fields:    Translation:Humans
  33. Kehl KL, Schrag D, Hassett MJ, Uno H. Assessment of Temporal Selection Bias in Genomic Testing in a Cohort of Patients With Cancer. JAMA Netw Open. 2020 06 01; 3(6):e206976. PMID: 32511717.
    Citations: 5     Fields:    Translation:Humans
  34. Vaz-Luis I, Barroso-Sousa R, Di Meglio A, Hu J, Rees R, Sinclair N, Milisits L, Leone JP, Constantine M, Faggen M, Briccetti F, Block C, O'Neil K, Partridge A, Burstein H, Waks AG, Trippa L, Tolaney SM, Hassett M, Winer EP, Lin NU. Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study. J Clin Oncol. 2020 07 20; 38(21):2390-2397. PMID: 32330102.
    Citations: 3     Fields:    Translation:Humans
  35. Hassett MJ, Li H, Burstein HJ, Punglia RS. Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes. Breast Cancer Res Treat. 2020 May; 181(1):43-51. PMID: 32185586.
    Citations: 6     Fields:    Translation:Humans
  36. Hassett MJ, Somerfield MR, Giordano SH. Management of Male Breast Cancer: ASCO Guideline Summary. JCO Oncol Pract. 2020 08; 16(8):e839-e843. PMID: 32091951.
    Citations: 3     Fields:    Translation:Humans
  37. Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, Plichta JK, Ricker C, Roshal A, Ruddy KJ, Safer JD, Van Poznak C, Yung RL, Giordano SH. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020 06 01; 38(16):1849-1863. PMID: 32058842.
    Citations: 37     Fields:    Translation:Humans
  38. Ozanne EM, Soeteman DI, Frank ES, Clarke J, Hassett MJ, Stout NK, Punglia RS. Commentary: Creating a patient-centered decision aid for ductal carcinoma in situ. Breast J. 2020 07; 26(7):1498-1499. PMID: 32034829.
    Citations: 1     Fields:    Translation:Humans
  39. Kehl KL, Hassett MJ, Schrag D. Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era. Cancer Med. 2020 03; 9(6):2019-2029. PMID: 31989786.
    Citations: 6     Fields:    Translation:Humans
  40. Smyth LM, Zhou Q, Nguyen B, Yu C, Lepisto EM, Arnedos M, Hasset MJ, Lenoue-Newton ML, Blauvelt N, Dogan S, Micheel CM, Wathoo C, Horlings H, Hudecek J, Gross BE, Kundra R, Sweeney SM, Gao J, Schultz N, Zarski A, Gardos SM, Lee J, Sheffler-Collins S, Park BH, Sawyers CL, André F, Levy M, Meric-Bernstam F, Bedard PL, Iasonos A, Schrag D, Hyman DM. Characteristics and Outcome of AKT1E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry. Cancer Discov. 2020 04; 10(4):526-535. PMID: 31924700.
    Citations: 13     Fields:    Translation:Humans
  41. Uno H, Horiguchi M, Hassett MJ. Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2020 02; 25(2):91-93. PMID: 32043795; PMCID: PMC7011662.
    Citations: 1     Fields:    Translation:Humans
  42. Uno H, Horiguchi M, Hassett MJ. Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2019 Nov 19. PMID: 31744932.
    Citations:    
  43. Kehl KL, Elmarakeby H, Nishino M, Van Allen EM, Lepisto EM, Hassett MJ, Johnson BE, Schrag D. Assessment of Deep Natural Language Processing in Ascertaining Oncologic Outcomes From Radiology Reports. JAMA Oncol. 2019 Oct 01; 5(10):1421-1429. PMID: 31343664; PMCID: PMC6659158.
    Citations: 39     Fields:    
  44. Hassett MJ, Banegas M, Uno H, Weng S, Cronin AM, O'Keeffe Rosetti M, Carroll NM, Hornbrook MC, Ritzwoller DP. Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627. PMID: 31107629.
    Citations: 1     Fields:    Translation:Humans
  45. Carroll NM, Ritzwoller DP, Banegas MP, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ. Performance of Cancer Recurrence Algorithms After Coding Scheme Switch From International Classification of Diseases 9th Revision to International Classification of Diseases 10th Revision. JCO Clin Cancer Inform. 2019 03; 3:1-9. PMID: 30869998; PMCID: PMC6706070.
    Citations: 5     Fields:    Translation:Humans
  46. Uno H, Ritzwoller DP, Cronin AM, Carroll NM, Hornbrook MC, Hassett MJ. Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data. JCO Clin Cancer Inform. 2018 12; 2:1-10. PMID: 30652573; PMCID: PMC6338474.
    Citations: 8     Fields:    Translation:Humans
  47. Sinaiko AD, Chien AT, Hassett MJ, Kakani P, Rodin D, Meyers DJ, Fraile B, Rosenthal MB, Landrum MB. What drives variation in spending for breast cancer patients within geographic regions? Health Serv Res. 2019 02; 54(1):97-105. PMID: 30318592.
    Citations: 4     Fields:    Translation:Humans
  48. Zhang B, Lloyd W, Jahanzeb M, Hassett MJ. Use of Patient-Reported Outcome Measures in Quality Oncology Practice Initiative-Registered Practices: Results of a National Survey. J Oncol Pract. 2018 10; 14(10):e602-e611. PMID: 30207853.
    Citations: 6     Fields:    Translation:Humans
  49. Horiguchi M, Hassett MJ, Uno H. How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated? Oncologist. 2019 07; 24(7):867-871. PMID: 30201741.
    Citations: 4     Fields:    Translation:Humans
  50. Lin NU, Bichkoff H, Hassett MJ. Increasing Burden of Prior Authorizations in the Delivery of Oncology Care in the United States. J Oncol Pract. 2018 09; 14(9):525-528. PMID: 30125129.
    Citations: 3     Fields:    Translation:Humans
  51. Ritzwoller DP, Fishman PA, Banegas MP, Carroll NM, O'Keeffe-Rosetti M, Cronin AM, Uno H, Hornbrook MC, Hassett MJ. Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128. PMID: 30043542.
    Citations: 8     Fields:    Translation:Humans
  52. Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller DP. Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer. JNCI Cancer Spectr. 2018 Apr; 2(2):pky024. PMID: 30003196.
    Citations: 7     Fields:    
  53. Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res Treat. 2018 Oct; 171(3):777-781. PMID: 29946862.
    Citations: 3     Fields:    Translation:Humans
  54. Denduluri N, Chavez-MacGregor M, Telli ML, Eisen A, Graff SL, Hassett MJ, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Somerfield MR, Trudeau ME, Wolff AC, Giordano SH. Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2018 08 10; 36(23):2433-2443. PMID: 29787356.
    Citations: 48     Fields:    Translation:Humans
  55. Hassett MJ, Jiang W, Hughes ME, Edge S, Javid SH, Niland JC, Theriault R, Wong YN, Schrag D, Punglia RS. Treating Second Breast Events After Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018 04; 16(4):387-394. PMID: 29632058.
    Citations:    Fields:    Translation:Humans
  56. Weingart SN, Zhang L, Sweeney M, Hassett M. Chemotherapy medication errors. Lancet Oncol. 2018 04; 19(4):e191-e199. PMID: 29611527.
    Citations: 26     Fields:    Translation:Humans
  57. Ritzwoller DP, Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Kushi LC. Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281. PMID: 29873757; PMCID: PMC5972574.
    Citations: 21     Fields:    Translation:Humans
  58. Uno H, Hassett MJ, Wei LJ. Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer. JAMA. 2018 01 16; 319(3):306. PMID: 29340668.
    Citations: 1     Fields:    Translation:Humans
  59. Poorvu PD, Vaz-Luis I, Freedman RA, Lin NU, Barry WT, Winer EP, Hassett MJ. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States. Breast Cancer Res Treat. 2018 Apr; 168(3):727-737. PMID: 29332137.
    Citations: 6     Fields:    Translation:Humans
  60. Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98. PMID: 29135771.
    Citations: 22     Fields:    Translation:Humans
  61. Punglia RS, Jiang W, Lipsitz SR, Hughes ME, Schnitt SJ, Hassett MJ, Nekhlyudov L, Achacoso N, Edge S, Javid SH, Niland JC, Theriault RL, Wong YN, Habel LA. Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery. Breast Cancer Res Treat. 2018 02; 167(3):751-759. PMID: 29079937.
    Citations: 6     Fields:    Translation:Humans
  62. Hassett MJ. Usability Considerations in Oncology Electronic Medical Records. J Oncol Pract. 2017 08; 13(8):539-541. PMID: 28796970.
    Citations: 1     Fields:    Translation:Humans
  63. Chen CT, Li L, Brooks G, Hassett M, Schrag D. Medicare Spending for Breast, Prostate, Lung, and Colorectal Cancer Patients in the Year of Diagnosis and Year of Death. Health Serv Res. 2018 08; 53(4):2118-2132. PMID: 28748564.
    Citations: 6     Fields:    Translation:Humans
  64. Hassett MJ. Quality Improvement in the Era of Big Data. J Clin Oncol. 2017 10 01; 35(28):3178-3180. PMID: 28737974.
    Citations: 3     Fields:    Translation:Humans
  65. Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Fishman P, Ritzwoller DP. Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194. PMID: 28710943.
    Citations: 9     Fields:    Translation:Humans
  66. Vaz-Luis I, Hughes ME, Cronin A, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Trends in the use of mastectomy in women with small node-negative breast cancer treated at US academic centers. Breast Cancer Res Treat. 2016 Feb; 155(3):569-78. PMID: 26868124.
    Citations: 11     Fields:    Translation:Humans
  67. Lynch JA, Berse B, Petkov V, Filipski K, Zhou Y, Khoury MJ, Hassett M, Freedman AN. Implementation of the 21-gene recurrence score test in the United States in 2011. Genet Med. 2016 10; 18(10):982-90. PMID: 26890451.
    Citations: 4     Fields:    Translation:Humans
  68. Hassett MJ, Jiang W, Habel LA, Nekhlyudov L, Achacoso N, Acton L, Schnitt SJ, Schrag D, Punglia RS. Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community. Breast Cancer Res Treat. 2016 Feb; 155(3):541-9. PMID: 26843057; PMCID: PMC4767622.
    Citations: 3     Fields:    Translation:Humans
  69. Ganz PA, Hassett MJ, Miller DC. Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update. Am Soc Clin Oncol Educ Book. 2016; 35:e294-300. PMID: 27249735.
    Citations: 1     Fields:    Translation:Humans
  70. Hassett MJ, Schymura MJ, Chen K, Boscoe FP, Gesten FC, Schrag D. Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment. Cancer. 2016 Feb 01; 122(3):420-31. PMID: 26536043; PMCID: PMC4724235.
    Citations: 14     Fields:    Translation:Humans
  71. Hassett MJ, Uno H, Cronin AM, Carroll NM, Hornbrook MC, Ritzwoller D. Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2015 Jul 29. PMID: 26225443.
    Citations:    
  72. Tseng YD, Uno H, Hughes ME, Niland JC, Wong YN, Theriault R, Blitzblau RC, Moy B, Breslin T, Edge SB, Hassett MJ, Punglia RS. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):622-30. PMID: 26461004.
    Citations: 24     Fields:    Translation:Humans
  73. Vaz-Luis I, Hughes ME, Cronin AM, Rugo HS, Edge SB, Moy B, Theriault RL, Hassett MJ, Winer EP, Lin NU. Variation in type of adjuvant chemotherapy received among patients with stage I breast cancer: A multi-institutional study. Cancer. 2015 Jun 15; 121(12):1937-48. PMID: 25757412; PMCID: PMC4457605.
    Citations: 2     Fields:    Translation:Humans
  74. Hassett MJ, Ritzwoller DP, Taback N, Carroll N, Cronin AM, Ting GV, Schrag D, Warren JL, Hornbrook MC, Weeks JC. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73. PMID: 23222531.
    Citations: 55     Fields:    Translation:Humans
  75. Brooks GA, Li L, Uno H, Hassett MJ, Landon BE, Schrag D. Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer. Health Aff (Millwood). 2014 Oct; 33(10):1793-800. PMID: 25288424.
    Citations: 54     Fields:    Translation:Humans
  76. Hassett MJ, Neville BA, Weeks JC. The relationship between quality, spending and outcomes among women with breast cancer. J Natl Cancer Inst. 2014 Oct; 106(10). PMID: 25217776.
    Citations: 7     Fields:    Translation:Humans
  77. Hassett MJ, McNiff KK, Dicker AP, Gilligan T, Hendricks CB, Lennes I, Murray T, Krzyzanowska MK. High-priority topics for cancer quality measure development: results of the 2012 American Society of Clinical Oncology Collaborative Cancer Measure Summit. J Oncol Pract. 2014 May; 10(3):e160-6. PMID: 24549319.
    Citations: 6     Fields:    Translation:Humans
  78. Dalby CK, Anastas S, Brady L, Hassett MJ, Shulman LN, Jacobson JO. Implementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing. J Clin Oncol. 2013 Nov; 31(31_suppl):20. PMID: 28136255.
    Citations:    
  79. Shin J, Liang SY, Hassett MJ, Phillips KA, Haas JS. Utilization of cardiac monitoring tests in women with nonmetastatic breast cancer treated with trastuzumab. Per Med. 2013 Sep; 10(7):703-708. PMID: 29768759.
    Citations:    Fields:    
  80. Hassett MJ, Elkin EB. What does breast cancer treatment cost and what is it worth? Hematol Oncol Clin North Am. 2013 Aug; 27(4):829-41, ix. PMID: 23915747.
    Citations: 4     Fields:    Translation:Humans
  81. Weingart SN, Zhu J, Young-Hong J, Vermilya HB, Hassett M. Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior? J Oncol Pharm Pract. 2014 Jun; 20(3):163-71. PMID: 23804625.
    Citations: 3     Fields:    Translation:Humans
  82. Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. J Natl Cancer Inst. 2013 Jun 05; 105(11):774-81. PMID: 23644480.
    Citations: 6     Fields:    Translation:Humans
  83. Brooks GA, Li L, Sharma DB, Weeks JC, Hassett MJ, Yabroff KR, Schrag D. Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst. 2013 May 01; 105(9):634-42. PMID: 23482657.
    Citations: 40     Fields:    Translation:Humans
  84. Hassett MJ, Wheelock A, Thorsen CM, Kaplan C, Ozanne E. Cost of cancer care: The impact of disclosure on willingness to pay and treatment preferences. J Clin Oncol. 2012 Dec; 30(34_suppl):15. PMID: 28146906.
    Citations:    
  85. Abel GA, Chen K, Taback N, Hassett MJ, Schrag D, Weeks JC. Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer. 2013 Mar 01; 119(5):1065-72. PMID: 23132702.
    Citations: 6     Fields:    Translation:Humans
  86. Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett M. Improving electronic oral chemotherapy prescription: can we build a safer system? J Oncol Pract. 2012 Nov; 8(6):e168-73. PMID: 23598852.
    Citations: 6     Fields:    Translation:Humans
  87. Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012 Jul 18; 104(14):1102-5. PMID: 22773822.
    Citations: 17     Fields:    Translation:Humans
  88. Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong YN, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ. Cancer. 2012 Dec 15; 118(24):6022-30. PMID: 22674478; PMCID: PMC3496800.
    Citations: 6     Fields:    Translation:Humans
  89. Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol. 2012 Jun 20; 30(18):2218-26. PMID: 22585699; PMCID: PMC3397718.
    Citations: 64     Fields:    Translation:Humans
  90. Weingart SN, Li JW, Zhu J, Morway L, Stuver SO, Shulman LN, Hassett MJ. US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012 Jan; 8(1):7-12. PMID: 22548004.
    Citations: 10     Fields:    
  91. Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN. Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec; 37(12):568-75. PMID: 22235542.
    Citations: 7     Fields:    Translation:Humans
  92. Brawarsky P, Neville BA, Fitzmaurice GM, Hassett MJ, Haas JS. Use of annual mammography among older women with ductal carcinoma in situ. J Gen Intern Med. 2012 May; 27(5):500-5. PMID: 22005943; PMCID: PMC3326107.
    Citations: 6     Fields:    Translation:Humans
  93. Elkin EB, Marshall DA, Kulin NA, Ferrusi IL, Hassett MJ, Ladabaum U, Phillips KA. Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med. 2011 Oct; 13(10):853-60. PMID: 21637102; PMCID: PMC3774033.
    Citations: 9     Fields:    Translation:Humans
  94. Arnaout A, Leblebjian H, Bartel S, Hassett MJ. Relative dose intensity (RDI) assessment in an academic center. J Clin Oncol. 2011 Sep 20; 29(27_suppl):139. PMID: 27958144.
    Citations:    
  95. Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov; 130(2):619-26. PMID: 21681446.
    Citations: 5     Fields:    Translation:Humans
  96. Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PR, Boscoe FP, Sinclair AH, Schymura MJ, Schrag D. Adjuvant hormone therapy use in early-stage breast cancer patients insured by the New York State Medicaid program. J Clin Oncol. 2011 May 20; 29(15_suppl):6031. PMID: 28021935.
    Citations:    
  97. Hassett MJ, Neville BA, Weeks JC. The relationship between cost, quality, and outcomes among women with breast cancer in SEER-Medicare. J Clin Oncol. 2011 May 20; 29(15_suppl):6001. PMID: 28022003.
    Citations:    
  98. Arvold ND, Punglia RS, Hughes ME, Jiang W, Edge SB, Javid SH, Laronga C, Niland JC, Theriault RL, Weeks JC, Wong Y, Lee SJ, Hassett MJ. Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation. J Clin Oncol. 2011 May 20; 29(15_suppl):1042. PMID: 28020685.
    Citations:    
  99. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May; 7(3 Suppl):e1s-7s. PMID: 21886507.
    Citations: 7     Fields:    
  100. Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May 01; 17(5 Spec No):e174-81. PMID: 21711068.
    Citations: 3     Fields:    Translation:Humans
  101. Hassett MJ, Rao SR, Brozovic S, Stahl JE, Schwartz JH, Maloney B, Jacobson JO. Chemotherapy-related hospitalization among community cancer center patients. Oncologist. 2011; 16(3):378-87. PMID: 21349949.
    Citations: 35     Fields:    Translation:Humans
  102. Hu YY, Weeks CM, In H, Dodgion CM, Golshan M, Chun YS, Hassett MJ, Corso KA, Gu X, Lipsitz SR, Greenberg CC. Impact of neoadjuvant chemotherapy on breast reconstruction. Cancer. 2011 Jul 01; 117(13):2833-41. PMID: 21264833; PMCID: PMC3164976.
    Citations: 10     Fields:    Translation:Humans
  103. Punglia RS, Hassett MJ. Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors. J Clin Oncol. 2010 Sep 20; 28(27):4108-10. PMID: 20697089.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  104. Hassett MJ. The full burden of cancer. Oncologist. 2010; 15(8):793-5. PMID: 20667965.
    Citations: 2     Fields:    Translation:Humans
  105. Phillips KA, Marshall DA, Haas JS, Elkin EB, Liang SY, Hassett MJ, Ferrusi I, Brock JE, Van Bebber SL. Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer. 2009 Nov 15; 115(22):5166-74. PMID: 19753618; PMCID: PMC2783254.
    Citations: 23     Fields:    Translation:Humans
  106. Hassett MJ, O'Malley AJ, Keating NL. Factors influencing changes in employment among women with newly diagnosed breast cancer. Cancer. 2009 Jun 15; 115(12):2775-82. PMID: 19365847; PMCID: PMC2720601.
    Citations: 27     Fields:    Translation:Humans
  107. Haas J, Phillips KA, Hassett MJ, Liang S, Keohane C, Armstrong J, Toscano M. Breast cancer testing strategies and the utilization of targeted therapies: Data from the real world. J Clin Oncol. 2009 May 20; 27(15_suppl):e17518. PMID: 27963272.
    Citations:    
  108. Rao SR, Hassett M, Schwartz JH, Maloney B, Jacobson JO. Admissions for chemotherapy-related serious adverse effects (CR-SAEs) and rates of mortality among community cancer center patients. J Clin Oncol. 2009 May 20; 27(15_suppl):6571. PMID: 27963798.
    Citations:    
  109. Hassett MJ, Weeks JC. Identifying high-priority quality measures for breast cancer quality improvement using data from a nationally representative sample. J Clin Oncol. 2009 May 20; 27(15_suppl):6507. PMID: 27964009.
    Citations:    
  110. Hassett MJ, Griggs JJ. Disparities in breast cancer adjuvant chemotherapy: moving beyond yes or no. J Clin Oncol. 2009 May 01; 27(13):2120-1. PMID: 19307493.
    Citations: 12     Fields:    Translation:Humans
  111. Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC. Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer. 2009 Feb 15; 115(4):716-24. PMID: 19152430; PMCID: PMC3291169.
    Citations: 11     Fields:    Translation:Humans
  112. Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral health services for women who have breast cancer. J Clin Oncol. 2009 Feb 10; 27(5):706-12. PMID: 19114705.
    Citations:    Fields:    Translation:Humans
  113. Hassett MJ, Hughes ME, Niland JC, Edge SB, Theriault RL, Wong YN, Wilson J, Carter WB, Blayney DW, Weeks JC. Chemotherapy use for hormone receptor-positive, lymph node-negative breast cancer. J Clin Oncol. 2008 Dec 01; 26(34):5553-60. PMID: 18955448; PMCID: PMC2651096.
    Citations: 13     Fields:    Translation:Humans
  114. Hassett MJ, Hughes ME, Niland JC, Ottesen R, Edge SB, Bookman MA, Carlson RW, Theriault RL, Weeks JC. Selecting high priority quality measures for breast cancer quality improvement. Med Care. 2008 Aug; 46(8):762-70. PMID: 18665055.
    Citations: 16     Fields:    Translation:Humans
  115. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst. 2006 Aug 16; 98(16):1108-17. PMID: 16912263.
    Citations: 133     Fields:    Translation:Humans
  116. Hassett MJ, Pakes J, O'Malley AJ, Newhouse JP, Earle CC. Chemotherapy-related serious adverse events and health care expenditures among commercially insured women with breast cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):6000. PMID: 27945098.
    Citations:    
  117. Leo RJ, Burnett GJ, Hassett MJ. Psychosis associated with hypopituitarism. Gen Hosp Psychiatry. 1998 Jul; 20(4):248-54. PMID: 9719905.
    Citations: 5     Fields:    Translation:Humans
  118. Hassett MJ, Glick PL, Karamanoukian HL, Rossman JE, Wilcox DT, Azizkhan RG. Pathophysiology of congenital diaphragmatic hernia. XVI: Elevated pulmonary collagen in the lamb model of congenital diaphragmatic hernia. J Pediatr Surg. 1995 Aug; 30(8):1191-4. PMID: 7472980.
    Citations: 3     Fields:    Translation:HumansAnimals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hassett's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (247)
Explore
_
Co-Authors (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.